Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT – Get Free Report) shares rose 1.9% during mid-day trading on Wednesday . The stock traded as high as $3.57 and last traded at $3.28. Approximately 16,082 shares changed hands during trading, a decline of 96% from the average daily volume of 451,868 shares. The stock had previously closed at $3.22.
Lixte Biotechnology Stock Up 1.2 %
The firm has a market capitalization of $7.33 million, a PE ratio of -1.21 and a beta of -0.28. The firm’s 50 day moving average price is $2.86 and its two-hundred day moving average price is $2.56.
Lixte Biotechnology (NASDAQ:LIXT – Get Free Report) last posted its quarterly earnings data on Tuesday, March 19th. The company reported ($0.41) EPS for the quarter.
Lixte Biotechnology Company Profile
Lixte Biotechnology Holdings, Inc operates as a drug discovery company that uses biomarker technology to design novel compounds for serious common diseases. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development.
Recommended Stories
- Five stocks we like better than Lixte Biotechnology
- CD Calculator: Certificate of Deposit Calculator
- 3 Stocks Leading the U.S. Agriculture Comeback
- What Investors Need to Know About Upcoming IPOs
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Airline Stocks – Top Airline Stocks to Buy Now
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Lixte Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lixte Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
